RESEARCH-USE BIOSIMILAR ANTIBODY
Docaravimab
Monoclonal antibody · IgG2b
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
TARGETRabies Virus Strain ERA GP Ectodomain Epitope G-III
YMonoclonal antibody
CATALOGSC-BS-628
CATALOG NUMBERSC-BS-628
MOLECULAR WEIGHTApprox. 146.48 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
Docaravimab is a recombinant research-use antibody directed against Rabies Virus Strain ERA GP Ectodomain Epitope G-III.